Merck Registers HIV Drug With Medicines Patent Pool, Allowing For Production Of Low-Cost Pediatric Formulations

Associated Press: Merck grants free license for pediatric HIV drug
“Drugmaker Merck & Co. has granted a free license allowing one of its HIV medicines to be made and sold inexpensively for use in young children in poor countries hard hit by the AIDS virus…” (Johnson, 2/24).

Reuters: Merck places children’s HIV drug in shared non-profit patent pool
“…The non-profit Medicines Patent Pool (MPP), which aims to persuade leading drug companies to share rights to their products with generic manufacturers, said on Tuesday the deal for Merck’s raltegravir would add to the treatment arsenal…” (Hirschler, 2/24).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.